LBel ParisRenovance Jour (Ventura International LTD)
Welcome to the PulseAid listing for the LBel Paris drug offered from Ventura International LTD. This pharmaceutical is classified as a HUMAN OTC DRUG. Below, you can view details for this drug, such as its dosage form, route of delivery, start market/end market dates, and more. We have also randomly listed additional pharmaceuticals used in the same HUMAN OTC DRUG drug type category.
| LABELER NAME / MANUFACTURER: | Ventura International LTD |
| NON-PROPRIETARY NAME: | Octinoxate, Octocrylene, and Oxybenzone |
| SUBSTANCE NAME: | OCTINOXATE; OCTOCRYLENE; OXYBENZONE |
| TYPE: | HUMAN OTC DRUG |
| PHARMA CLASS: | |
| ROUTE: | TOPICAL |
| DOSAGE FORM: | CREAM |
| MARKETING CATEGORY NAME: | OTC MONOGRAPH FINAL |
| START MARKETING DATE: | 2010-08-15 |
| END MARKETING DATE: | 0000-00-00 |
LBel Paris Renovance Jour HUMAN OTC DRUG Details:
| Item Description | LBel Paris Renovance Jour from Ventura International LTD |
| LABELER NAME: | Ventura International LTD |
| DEA SCHEDULE: |
|
| ACTIVE STRENGTH: | .075; .05; .03(g/g; g/g; g/g) |
| START MARKETING DATE: | 2010-08-15 |
| END MARKETING DATE: | 0000-00-00 |
| PRODUCT ID: | 14783-018_0c3c71b9-8f8d-4de9-8fe4-04a2cb405093 |
| PRODUCT NDC: | 14783-018 |
| APPLICATION NUMBER: | part352 |
Other OCTINOXATE; OCTOCRYLENE; OXYBENZONE Pharmaceutical Manufacturers / Labelers:
